Suppr超能文献

甲状腺激素替代治疗对甲状腺功能减退患者脂蛋白(a)、脂质和载脂蛋白的影响。

Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism.

作者信息

Martínez-Triguero M L, Hernández-Mijares A, Nguyen T T, Muñoz M L, Peña H, Morillas C, Lorente D, Lluch I, Molina E

机构信息

Endocrinology and Analysis Department, Hospital Universitario Dr. Peset, Valencia, Spain.

出版信息

Mayo Clin Proc. 1998 Sep;73(9):837-41. doi: 10.4065/73.9.837.

Abstract

OBJECTIVE

To study the effect of thyroid hormone replacement on total cholesterol, low-density lipoprotein cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), apolipoprotein A-I and B-100, and lipoprotein(a) [Lp(a)] in subjects with hypothyroidism.

MATERIAL AND METHODS

In 17 patients with clinical primary hypothyroidism, studies were done before and after thyroid hormone replacement therapy. Free thyroxine and thyrotropin were determined by chemiluminescent assay. Total cholesterol and triglycerides were measured by enzymatic methods, and HDL-C was measured after dextran sulfate-MgCl2 precipitation. Apolipoprotein A-I and B-100 were assayed by immunonephelometry. For measurement of Lp(a), we used a sequential sandwich enzyme-linked immunosorbent assay.

RESULTS

After levothyroxine treatment, the mean concentration of thyrotropin decreased from 91.4 to 3.7 microIU/mL, and free thyroxine increased from 0.5 to 1.2 ng/ dL. Total cholesterol, triglycerides, HDL-C, low-density lipoprotein cholesterol, and apolipoprotein A-I and B-100 decreased after thyroid hormone replacement therapy. Lp(a) levels also decreased significantly (P<0.05) after treatment, from a mean of 33.4 to 25.6 mg/dL.

CONCLUSION

Hypothyroidism is associated with an increase in total cholesterol, triglycerides, HDL-C, apolipoprotein A-I and B-100, and Lp(a). A reduction in lipid and lipoprotein levels after thyroid hormone replacement in our study cohort resulted in a less atherogenic profile.

摘要

目的

研究甲状腺激素替代治疗对甲状腺功能减退患者总胆固醇、低密度脂蛋白胆固醇、甘油三酯、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A-I和B-100以及脂蛋白(a) [Lp(a)]的影响。

材料与方法

对17例临床原发性甲状腺功能减退患者在甲状腺激素替代治疗前后进行研究。采用化学发光法测定游离甲状腺素和促甲状腺激素。采用酶法测定总胆固醇和甘油三酯,经硫酸葡聚糖-氯化镁沉淀后测定HDL-C。采用免疫比浊法测定载脂蛋白A-I和B-100。对于Lp(a)的测定,我们使用了连续夹心酶联免疫吸附测定法。

结果

左甲状腺素治疗后,促甲状腺激素的平均浓度从91.4降至3.7 μIU/mL,游离甲状腺素从0.5升至1.2 ng/dL。甲状腺激素替代治疗后,总胆固醇、甘油三酯、HDL-C、低密度脂蛋白胆固醇以及载脂蛋白A-I和B-100均下降。治疗后Lp(a)水平也显著下降(P<0.05),从平均33.4降至25.6 mg/dL。

结论

甲状腺功能减退与总胆固醇、甘油三酯、HDL-C、载脂蛋白A-I和B-100以及Lp(a)升高有关。在我们的研究队列中,甲状腺激素替代治疗后血脂和脂蛋白水平降低,导致动脉粥样硬化风险降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验